On November 12, 2024, the American Society of Addiction Medicine (ASAM) held a meeting with the patient advisory panel, which includes two members of our organization, to discuss the status of the benzodiazepine deprescribing guidelines….
In 2022, our current medical director, Nicole Lamberson, PA, and our late medical director, Dr. Christy Huff, participated in the James Lind Alliance Priority Setting Partnership, known as PROTECT PSP (Priorities for Future Research on…
Malissa Pistillo shares her story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
On October 6, 2019, journalist Lisa Ling profiled the lived experiences of those impacted by benzodiazepine injury on her show This is Life with Lisa Ling. In the 44-minute segment, Ling interviewed several benzodiazepine survivors…
Asuka shares her story of benzodiazepine harm and healing for our #BenzoStories series. #BenzoStories is a series by our nonprofit, Benzodiazepine Information Coalition, sharing powerful stories of patient harm associated with prescribed benzodiazepines. To stay…
On September 6, 2024, we had the privilege of educating students at Eastern Virginia Medical School’s Physician Assistant Program about benzodiazepines. This marked our second opportunity to attend the event this year, following our earlier…
We recently updated our website with information about the risks of phenobarbital detox and the lack of evidence supporting its use in detoxing compliant, physically dependent benzodiazepine patients. You can view the content by clicking…
A recent study published on August 7, 2024 in the European Journal of Preventive Cardiology raises alarms about the cardiovascular risks associated with certain hypnotic agents used to treat insomnia. Conducted by researchers from China, this study…
